Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Alnylam sues Moderna and Pfizer over key vaccine ingredient

March 23, 2022 Research and Development

Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company, has sued Moderna and Pfizer over allegations that the firms used patented nanoparticle technology …
News

ONS says no evidence that COVID-19 vaccines lead to young deaths

March 23, 2022 Research and Development

The Office for National Statistics (ONS) has said that there is no evidence that COVID-19 vaccines have led to an …
News

Pfizer to supply UNICEF oral COVID-19 treatment for low- and middle-income countries

March 23, 2022 Research and Development

Pfizer have announced the signing of a supply agreement with the United Nations Children’s Fund (UNICEF), to deliver up to …
News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
Appointment

Sanofi and Seagen collaborate to develop novel antibody-drug conjugates

March 16, 2022 Research and Development

Sanofi and Seagen announced an exclusive collaboration agreement to design, develop, and commercialise antibody-drug conjugates (ADCs) for up to three …
News
national-cancer-institute-uurfmwa25f0-unsplash

NICE guidance for treating relapsed and refractory multiple myeloma

March 16, 2022 Research and Development

NICE has published guidance from the new cancer drug, daratumumab, for the treatment of relapsed and refractory myeloma. Around 350 …
News

FDA approves Symbicort to treat asthma and COPD

March 16, 2022 Research and Development

The FDA has approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, for the treatment of …
News

FDA clearance for clinical surveillance solution

March 16, 2022 Research and Development

The latest Philips Capsule Surveillance solution has received market clearance from the FDA, paving the way for widespread deployment across …
News

Vicore adds to rare lung disease pipeline with PAH indication

March 9, 2022 Research and Development

Vicore Pharma has announced plans to initiate a clinical trial with C21 in pulmonary arterial hypertension (PAH).
News

NICE draft guidance does not recommend pembrolizumab plus chemo for triple negative breast cancer

March 9, 2022 Research and Development

Draft guidance published by NICE for public consultation does not recommend pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) for …
News

Omicron sub-variant BA.2 makes up 11.6% of COVID-19 variants in US

March 9, 2022 Research and Development

The CDC said that the BA.2 sub-variant of Omicron is estimated to be 11.6% of the coronavirus variants circulating in …
News

MHRA authorisation of new treatment for chronic kidney disease associated with diabetes

March 9, 2022 Research and Development

The MHRA has authorised the use of Kerendia® (finerenone) (10mg or 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) …
News

First smart connected insulin pens made available on NHS

March 2, 2022 Research and Development

Today, Novo Nordisk will launch the first smart connected insulin pens to be made available on NHS prescription. The pens, …
News

Fera Pharmaceuticals receives Orphan Drug Designation from FDA for sickle cell treatment

March 2, 2022 Research and Development

The FDA has granted an Orphan Drug Designation for naproxcinod for the treatment of sickle cell disease, which affects an …
News

HPV vaccines could mean only one smear test a lifetime

March 2, 2022 Research and Development

A leading scientist has said that women who have the HPV vaccine may need only one smear test to prevent …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025